Cargando…
Bumetanide Effects on Resting-State EEG in Tuberous Sclerosis Complex in Relation to Clinical Outcome: An Open-Label Study
Neuronal excitation-inhibition (E/I) imbalances are considered an important pathophysiological mechanism in neurodevelopmental disorders. Preclinical studies on tuberous sclerosis complex (TSC), suggest that altered chloride homeostasis may impair GABAergic inhibition and thereby E/I-balance regulat...
Autores principales: | Juarez-Martinez, Erika L., van Andel, Dorinde M., Sprengers, Jan J., Avramiea, Arthur-Ervin, Oranje, Bob, Scheepers, Floortje E., Jansen, Floor E., Mansvelder, Huibert D., Linkenkaer-Hansen, Klaus, Bruining, Hilgo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9134117/ https://www.ncbi.nlm.nih.gov/pubmed/35645706 http://dx.doi.org/10.3389/fnins.2022.879451 |
Ejemplares similares
-
Effects of bumetanide on neurodevelopmental impairments in patients with tuberous sclerosis complex: an open-label pilot study
por: van Andel, Dorinde M., et al.
Publicado: (2020) -
Bumetanide As a Candidate Treatment for Behavioral Problems in Tuberous Sclerosis Complex
por: Vlaskamp, Chantal, et al.
Publicado: (2017) -
Bumetanide for Irritability in Children With Sensory Processing Problems Across Neurodevelopmental Disorders: A Pilot Randomized Controlled Trial
por: van Andel, Dorinde M., et al.
Publicado: (2022) -
Measurement of excitation-inhibition ratio in autism spectrum disorder using critical brain dynamics
por: Bruining, Hilgo, et al.
Publicado: (2020) -
The sensory-reactivity PROM set: identification of a parent reported outcome measure set for autism spectrum disorder
por: van Andel, Dorinde M., et al.
Publicado: (2021)